We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current AXSM market cap is 3.24B. The company's latest EPS is USD -3.9547 and P/E is -17.34.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 16.85M | 24.37M | 94.58M | 46.7M | 57.79M |
| Operating Income | -42.45M | -55.72M | -6.54M | -59M | -62.3M |
| Net Income | -44.82M | -61.24M | -11.22M | -67.17M | -62.2M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 50.04M |
| Operating Income | -32.85M | -67.25M | -99.14M | -124.71M | -176.5M |
| Net Income | -30.97M | -68.35M | -102.9M | -130.4M | -187.13M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 338.96M | 331.48M | 389.18M | 611.64M | 600.86M |
| Total Liabilities | 181.6M | 221.92M | 277.37M | 332.83M | 331.35M |
| Total Equity | 157.36M | 109.56M | 111.81M | 278.8M | 269.51M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 15.38M | 220.55M | 186.13M | 87.79M | 331.48M |
| Total Liabilities | 14.44M | 41.83M | 72.34M | 72.16M | 221.92M |
| Total Equity | 938k | 178.72M | 113.79M | 15.63M | 109.56M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -88.95M | -116.51M | -5.82M | -61.17M | -114.72M |
| Investing | -53.52M | -53.7M | -71k | -204k | -575k |
| Financing | 283.52M | 284.58M | 51.57M | 297.65M | 331.02M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -30.05M | -46.38M | -78.46M | -108.23M | -116.51M |
| Investing | -33k | -16k | -46k | -307k | -53.7M |
| Financing | 10.03M | 252.39M | 42.41M | 11.13M | 284.58M |
| Market Cap | 3.24B |
| Price to Earnings Ratio | -17.34 |
| Price to Sales Ratio | 64.87 |
| Price to Cash Ratio | 16.16 |
| Price to Book Ratio | 29.63 |
| Dividend Yield | - |
| Shares Outstanding | 47.32M |
| Average Volume (1 week) | 608.27k |
| Average Volume (1 Month) | 645.41k |
| 52 Week Change | -10.29% |
| 52 Week High | 91.29 |
| 52 Week Low | 53.71 |
| Spread (Intraday) | 0.27 (0.39%) |
| Company Name | Axsome Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.axsome.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
